Galileo Research Facts No. 120: Can Galileo Therapy increase muscle and lung function in Cystic Fibrosis patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 120: Can Galileo Therapy increase muscle and lung function in Cystic Fibrosis patients?

Posted by
This study investigated the effects of Galileo Therapy on lung and muscle function of adult Cystic Fibrosis patients (age 24-47, 20-25Hz, pos. 1, 10*3 min./week, 3 months). The results showed that Galileo Therapy could significantly improve lung function (+5%) and muscle function e.g. in the chair rising test (CRT) in muscle power (+16%) and muscle force (+34%)...
Continue reading
Galileo Research Facts No. 118: Can Galileo Therapy + HRT be more effective for bone density than strength training + HRT?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 118: Can Galileo Therapy + HRT be more effective for bone density than strength training + HRT?

Posted by
This study investigated the effects of Galileo Therapy vs. machine based strength training over a period of 1 year (60 min./week) (25Hz, Pos. 3-4, up to 15kg add. weights). Both received hormone replacement therapy (HRT). The control group received strength training at 6 different strength machines (Schnell). The Galileo group showed especially in combination with HRT significant higher effects with up to 3,7% increase aBMD...
Continue reading
GRFS, Therapy

Galileo Research Facts No. 116: Can high frequency Galileo Therapy improve blood-flow in spinal cord injury?

Posted by
This study investigated the effects of Galileo Therapy on blood-flow in spinal cord injury (SCI, ASIA A) patients. They received Galileo Therapy on a Galileo Delta tilt-table (45° tilt, 10-30Hz, pos. 2.5, 60° flexed knees, 3 min., then 2 min. test, blood-flow was measured using ultrasound Doppler). The blood flow improved significantly with increasing frequency and time by up to 54% compared to rest (also at 45° tilt)...
Continue reading
GRFS, Therapy

Galileo Research Facts No. 114: Can Galileo Therapy improve sensory perception in Diabetes Type 2 patients?

Posted by
This study investigated the effects of Galileo Therapy on the sensory perception (perception thresholds) in Diabetes Type 2 patients with diagnosed peripheral neuropathy (12Hz, pos. 1-3, 30° bent knees, 11 min., 3/week, 6 weeks). The control group received identical exercises without vibration. Compared to the control group the Galileo group showed a significant improvement of sensory perception by up to 21% (vibration)...
Continue reading
Galileo Research Facts No. 112: Can Galileo Therapy improve muscle power and balance in MS patients?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 112: Can Galileo Therapy improve muscle power and balance in MS patients?

Posted by
This study investigated safety and the effects of Galileo Therapy on muscle power, balance, flexibility and quality of life in MS (Multiple Sclerosis) patients (15-25Hz, pos. 2.5-4.5, 5-8x1min, 3/week, 8weeks, increasing Intensity). The Galileo group showed significant improvements in Balance (+12,8%), Functional Reach Test (+14.2%), muscle power (Timed up and Go, +10%) and FS-36 Mental Health (+9%)...
Continue reading
Galileo Research Facts No. 107: Can 3 weeks of Galileo Therapy improve power and endurance in COPD patients?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 107: Can 3 weeks of Galileo Therapy improve power and endurance in COPD patients?

Posted by
This pilot study examined the effects of 3 weeks of Galileo Therapy on muscle power and endurance measured by 6 minutes walk test in COPD in-patients. (25Hz, squat, 4*2 min. 5/week, 3 weeks). The control group received identical therapy without Galileo. The Galileo group showed a highly significant improvement in the walking distance by 23% or 68m which is equivalent to over two times the MCID...
Continue reading
Galileo Research Facts No. 106: Can 8 weeks of Galileo Therapy decrease inflammation markers?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 106: Can 8 weeks of Galileo Therapy decrease inflammation markers?

Posted by
This case study reported the results of Galileo Therapy in a patient with Anti-Jo-1-Syndrome (auto-immune disease) on inflammation markers like CK, IL-8 and TNF-alpha (26Hz, pos. 2, 6*2 min. + 12 Hz, 3min. cool-down, week, 2 months). Additional therapy was not changed during this time. The results show a significant decrease of the inflammation makers CK, IL-8 and TNF-alpha after 8 weeks by up to 61%...
Continue reading
Galileo Research Facts No. 102: Can Galileo Therapy improve balance in Fibromyalgia patients?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 102: Can Galileo Therapy improve balance in Fibromyalgia patients?

Posted by
This study investigates the effects of Galileo Therapy on balance in Fibromyalgia patients (12,5Hz, 6* 30-60sec., 3/week, 12 weeks). Both groups received standard physiotherapy. The control group received no additional therapy. While the control group decreased in many tested parameters of balance ability by up to 20% the Galileo Therapy group improved by up to 47%...
Continue reading
Galileo Research Facts No. 98: Can Galileo Therapy at work decrease subjective back pain?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 98: Can Galileo Therapy at work decrease subjective back pain?

Posted by
This study documented the effects of workplace-based Galileo Therapy on subjective back pain in individuals with chronic lower-back pain (10-30Hz, slightly bent legs, pos. 1-3, 15 min., 2-3/weeks, 3 months). The control group received no therapy. While the control group slightly decreased the Galileo Therapy group improved by up to 4.5% and showed a tendency to decrease days of sick-leave per month...
Continue reading
Galileo Research Facts No. 94: Can Galileo Therapy improve the disability status of MS patients?
17 Sep
GRFS, Therapy

Galileo Research Facts No. 94: Can Galileo Therapy improve the disability status of MS patients?

Posted by
This study investigated the effects of 8 weeks of Galileo Therapy on different disease related scores (PDDS, MSCF) in MS (Multiple Sclerosis) patients (20Hz, pos. 1.5, 5*1 min., 3/week, 8 weeks, 20° bent legs). The results show not only improvements in PDDS and PSAT-3 by up to 18% but also an increase in HSFC (MS Functional Composite: walking distance, hand function, calculation test) in average by 0.36SD...
Continue reading